Translational Neurodegeneration is a open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. It aims to provide an forum for international researchers and practitioners to discuss all areas of neurodegenerative diseases including epidemiology, etiology, pathogenesis, diagnosis, management and prevention, as well as their molecular, biochemical and physiological aspects. Our goal is to close the gap between basic research and clinical work in neurodegeneration.Topics of interest include but are not limited to the following areas of neurodegenerative diseases: Epidemiology and pathogenesisResearch into diagnosis and preventionResearch into the diease pathogenesis Development of new drugs and cell therapyDrug delivery RehabilitationBy offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration aims to create a novel interface between the fields of basic medical research, translational research and clinical research into Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease, and other related neurodegenerative diseases. It offers the opportunity for basis scientists, clinicians and physician-scientists to publish their research and clinical trials in a journal which is applicable to their specific field.
Translational Psychiatry is a sister journal to the well-established and number-one journal in psychiatry, Molecular Psychiatry*, but explores the more translational area between the research in neuroscience and conceptually novel treatments. The editorial team is led by Julio Licinio, MD, and includes a highly respected international editorial board. Together, the Translational Psychiatry editorial team and NPG look to further define and shape the field of psychiatry and neuroscience.
Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our
Please see our
Topics published in
• gross anatomy
• neuroanatomy
• histology
• immunohistochemistry
• comparative anatomy
• embryology
• molecular biology
• microscopic anatomy
• forensics
• imaging/radiology
• medical education
Priority will be given to studies that clearly articulate their relevance to the broader aspects of anatomy and how they can impact patient care.
Strengthening the ties between morphological research and medicine will foster collaboration between anatomists and physicians. Therefore,
The journal accepts the following article types:
1. Review articles
2. Original research papers
3. New state-of-the-art methods of research in the field of anatomy including imaging, dissection methods, medical devices and quantitation
4. Education papers (teaching technologies/methods in medical education in anatomy)
5. Commentaries
6. Letters to the Editor
7. Selected conference papers
All papers should be submitted in English and must be original work that is unpublished and not under consideration by another journal. An international Editorial Board and reviewers from the anatomical disciplines guarantee a rapid review of your paper within two to three weeks after submission.
Keywords:
Anatomy, neuroanatomy, developmental, biology, surgery, medicine, health care, histology, embryology, translational research, morphology, imaging, radiology, science, integration, molecular biology, basic science, forensics, MRI, 3D imaging
Translational Stroke Research covers basic, translational, and clinical studies. The Journal emphasizes novel approaches in order to help translate scientific discoveries from basic stroke research into the development of new strategies for prevention, assessment, treatment, and repair after stroke and other forms of neurotrauma. Translational Stroke Research focuses on translational research and is relevant to both basic scientists and physicians, including but not restricted to neuroscientists, vascular biologists, neurologists, neuroimagers, and neurosurgeons. The Journal provides an interactive forum for the dissemination of original research articles, review articles, research reports, letters, comments, and research protocols, in stroke and stroke related areas. Its distinguished editorial board is made up of leading stroke researchers and physicians from North America, Europe, and Asia.
CALL FOR PAPERS: 'Phenotypic Transformation of Smooth Muscle in Cerebrovascular Disease'Please bookmark this URL:
Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our
Please see our
Transplant Infectious Disease has been established as a forum for presenting the most current information on the prevention and treatment of infection complicating organ and bone marrow transplantation. The point of view of the journal is that infection and allograft rejection (or graft-versus-host disease) are closely intertwined, and that advances in one area will have immediate consequences on the other. The interaction of the transplant recipient with potential microbial invaders, the impact of immunosuppressive strategies on this interaction, and the effects of cytokines, growth factors, and chemokines liberated during the course of infections, rejection, or graft-versus-host disease are central to the interests and mission of this journal. Transplant Infectious Disease is aimed at disseminating the latest information relevant to the infectious disease complications of transplantation to clinicians and scientists involved in bone marrow, kidney, liver, heart, lung, intestinal, and pancreatic transplantation. The infectious disease consequences and concerns regarding innovative transplant strategies, from novel immunosuppressive agents to xenotransplantation, are very much a concern of this journal. In addition, this journal feels a particular responsibility to inform primary care practitioners in the community, who increasingly are sharing the responsibility for the care of these patients, of the special considerations regarding the prevention and treatment of infection in transplant recipients. As exemplified by the international editorial board, articles are sought throughout the world that address both general issues and those of a more restricted geographic import. Transplant Infectious Disease includes state-of-the-art review articles on important subjects, the results of clinical investigation, interesting case reports, and two recurring features: a clinical-pathologic conference and reviews of the basic science foundation of transplant infectious disease. Subjects covered include specific infections, the epidemiology of important infections, the interaction among immunosuppression and infection exposure, the diagnosis of specific infection, pathogenesis, and clinical management. Both basic science and clinical articles are featured. Where controversy exists, both sides of an issue are presented. This journal is meant to serve the needs of all clinicians and scientists involved in the study and care of organ and bone marrow transplant recipients.
The aim of the journal is to serve as a forum for the exchange of scientific information in the form of original and high quality papers in the field of transplantation. Clinical and experimental studies, as well as editorials, letters to the editors, and, occasionally, reviews on the biology, physiology, and immunology of transplantation of tissues and organs, are published. Publishing time for the latter is approximately six months, provided major revisions are not needed. The journal is published in yearly volumes, each volume containing twelve issues. Papers submitted to the journal are subject to peer review.
The most cited and influential journal in the field (with over 26,000 citations a year), Transplantation174; is published twice monthly and provides extensive coverage of the most important advances in transplantation. Using an electronic on-line submission and peer review tracking system, Transplantation174; is committed to rapid review and publication. The average time to first decision is now less than 21 days. Time to publication of accepted manuscripts continues to be shortened, with the Editorial team committed to a goal of 3 months from acceptance to publication.Consistently ranked among the top journals in Transplantation, Surgery and Immunology (2008 Journal Citation Reports), the journal covers areas including:Cell therapy and islet transplantationClinical transplantationExperimental transplantationImmunobiology and genomicsXenotransplantationExpert researchers and clinicians from around the world contribute original Articles, Overviews and Brief Reports in every pertinent specialty. Forums provide in-depth discussion of exciting developments and controversies in the field. Rapid Communications bring attention to cutting edge research.Issues also contain Analyses and Commentaries, Letters to the Editor and Announcements. Dedicated issues include the World Transplant Congress issue. Website: www.transplantjournal.com.